F-STAR THERAPEUTICS INC's ticker is FSTX and the CUSIP is 30315R107. A total of 55 filers reported holding F-STAR THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 14.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $79,537 | +24.3% | 12,585 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $64,000 | -19.0% | 12,585 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $79,000 | +75.6% | 12,585 | 0.0% | 0.00% | – |
| Q1 2022 | $45,000 | -28.6% | 12,585 | 0.0% | 0.00% | – |
| Q4 2021 | $63,000 | -33.0% | 12,585 | -1.9% | 0.00% | -100.0% |
| Q3 2021 | $94,000 | -14.5% | 12,835 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $110,000 | -20.9% | 12,835 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $139,000 | +9.4% | 12,835 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $127,000 | – | 12,835 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 574,996 | $2,944,000 | 1.06% |
| AlphaCentric Advisors LLC | 165,000 | $845,000 | 0.87% |
| DAFNA Capital Management LLC | 576,881 | $2,954,000 | 0.80% |
| Knott David M Jr | 235,945 | $1,208,000 | 0.51% |
| Atlas Venture Life Science Advisors, LLC | 599,524 | $3,070,000 | 0.34% |
| S. MUOIO & CO. LLC | 40,000 | $205,000 | 0.27% |
| Murchinson Ltd. | 162,624 | $833,000 | 0.24% |
| Connolly Sarah T. | 53,001 | $271,000 | 0.20% |
| BCK CAPITAL MANAGEMENT LP | 52,000 | $266,000 | 0.19% |
| Diametric Capital, LP | 44,449 | $228,000 | 0.12% |